PP8.1 – 00046 Safety, Viral Resuppression Dynamics, and Immunological Signatures of a PD-1 Inhibitor, Budigalimab, Among PWH During Analytical Treatment Interruption: Phase 1 Randomized Double- Blind Study
Title:
PP8.1 – 00046 Safety, Viral Resuppression Dynamics, and Immunological Signatures of a PD-1 Inhibitor, Budigalimab, Among PWH During Analytical Treatment Interruption: Phase 1 Randomized Double- Blind Study
Author:
Santos, A. Pires Dos Pringle, K. Krishnan, P. Nugent, A. Sharthiya, H. Dorr, P. Cohen, D. Abunimeh, M. Lalezari, L. Ramgopal, M. Routy, J.P.